Data / Form D filings / Centaur Bio Inc.
Centaur Bio Inc.: Form D filings
Centaur Bio Inc., a pharmaceuticals company in Charlotte, NC, filed 4 Form D notices with the SEC between 2023 and 2024. The latest, on September 10, 2024, reports $1 million sold of a $1 million offering to 26 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 7805 PEMSWOOD STREET, Charlotte, NC, 28277
- Phone
- (704) 807-6502
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1975017
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 10, 2024 | Amendment | $1,000,000 | $1,000,000 | 26 | Mar 5, 2024 | sec.gov | |
| Jul 30, 2024 | New notice | $1,000,000 | $471,000 | $529,000 | 11 | Mar 5, 2024 | sec.gov |
| Sep 7, 2023 | Amendment | $500,000 | $500,000 | 5 | Apr 6, 2023 | sec.gov | |
| Apr 27, 2023 | New notice | $500,000 | $430,000 | $70,000 | 4 | Apr 6, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael James Roberts | Executive Officer |
Other pharmaceuticals companies in North Carolina that filed recently
- Dignify Therapeutics, LLC $800,000 · Sep 25, 2026
Every Form D from the week of Sep 9, 2024 · All recent filings in North Carolina · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Centaur Bio Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.